Press Release from Medtronic March 22, 2021 This First-of-its-Kind Directional Lead Combines the Benefits of Directionality with the Power of Sensing DUBLIN, March 22, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the CE (Conformité Européenne) Mark for the SenSight™ directional lead system for Deep Brain Stimulation (DBS) therapy…
Botulinum Toxin Therapy: An Update
The therapeutic use of Botulinum Toxin (BT) was established some 40 years ago in ophthalmology by Dr Alan B Scott. Soon its use spread into the therapy of various dystonia indications. Ever since, it has been the backbone of dystonia treatment. Average subject-ive improvement is for most indications in the order of 70 to…
New Artificial Intelligence Platform Diagnoses Focal Dystonia with High Accuracy in Less Than One Second
This article was published in Dystonia Dialogue, Winter issue 2020 of DMRF (Dystonia Medical Research Foundation in the US), and we are happy to share it with our readers. The article is about the recently published research using a new diagnostic tool diagnosing dystonia from MRI. Researchers at Massachusetts Eye and Ear in Boston have…
DBS in Dystonia patients: An interview featuring Profs. Ferreira and Coelho from University Hospital of Santa Maria, in Lisbon.
The following article makes reference to certain companies and their products and any opinions expressed should not be taken to be the views of Dystonia Europe or its members. The articles are written by respected authors and are provided for the information of Dystonia Europe News readers. Dystonia is a heterogenous disease, which dramatically affects the…
Specialized Physical Therapy Reduces Disability and Pain in Cervical Dystonia
September the 21st was a memorable day for Joost van den Dool. On that day he successfully defended his PhD thesis at the University of Groningen in the Netherlands. His research focused on the effectiveness of a standardized physical therapy program for patients…
